Margin Compass

Margin Compass

Recommends how to split Medicare Part B product purchasing across a therapeutic class to meet your practice's profit, contract, or biosimilar-mix goal.

Loading CMS ASP data…

Therapeutic class & volume

Total units across every product in the class for the period above — pull from EHR/PM order history, trailing average or forecast. Tier thresholds you enter as "absolute units" use this same period.

Goal

Reimbursement assumptions

Medicare Part B ASP methodology
%
%
%

ASP+6% (SSA §1847A), reduced by the 2% Medicare sequestration cut applied only to the 80% Medicare-paid portion — beneficiary coinsurance is unaffected.

Effective net add-on to ASP—

WAC price list

No price list uploaded yet — WAC won't auto-fill on product cards until you add one.

A CSV from your distributor, GPO contract sheet, or a Redbook/Medi-Span export — any file with a product/drug name column and a WAC or unit-price column. Nothing leaves this page except into the app's own database; the file itself is never sent anywhere else.

Products in this class

Saved scenarios

Shared with anyone who has this page's link

No saved scenarios yet.

Compliance note. Purchasing and rebate economics must never influence which product is clinically appropriate for an individual patient — product selection stays a clinical decision. This tool only informs which SKU/contract to route volume through once products are clinically interchangeable. Any rebate or discount arrangement should be reviewed by counsel against the Anti-Kickback Statute, Stark Law, and applicable safe harbors before implementation. This is not legal advice. CMS ASP figures are reference data pulled from the published Payment Limit file for the current quarter; verify against the source file before relying on them for a purchasing decision.